Cidara Therapeutics Inc (CDTX) — Working Capital to Net Assets Ratio
Cidara Therapeutics Inc (CDTX) has a Working Capital to Net Assets ratio of 82.1% as of September 2025. Working capital of $346.98 Million (current assets of $442.82 Million minus current liabilities of $95.84 Million) is measured against net assets of $422.39 Million. A higher ratio indicates strong short-term liquidity financed by the equity base.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Cidara Therapeutics Inc Working Capital to Net Assets (2013–2024)
This chart shows how Cidara Therapeutics Inc's Working Capital to Net Assets ratio has evolved across 12 annual periods from 2013 to 2024. As of September 2025, the ratio stands at 82.1%, reflecting working capital of $346.98 Million against net assets of $422.39 Million USD. Explore CDTX long-term investment intensity to see how much of total assets are deployed in long-term investments.
Annual Working Capital to Net Assets for Cidara Therapeutics Inc (2013–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for Cidara Therapeutics Inc from 2013 to 2024, covering 12 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see total assets of Cidara Therapeutics Inc.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | 98.7% | $161.18 Million | $163.31 Million | $210.74 Million | $49.55 Million | ▲ +18.8 pp |
| 2023 | 79.9% | $-6.56 Million | $-8.21 Million | $60.85 Million | $67.42 Million | ▲ +105.5 pp |
| 2022 | -25.6% | $3.69 Million | $-14.44 Million | $45.09 Million | $41.40 Million | ▼ -200.3 pp |
| 2021 | 174.7% | $37.68 Million | $21.57 Million | $71.70 Million | $34.02 Million | ▲ +0.8 pp |
| 2020 | 173.8% | $18.63 Million | $10.71 Million | $57.19 Million | $38.56 Million | ▲ +79.7 pp |
| 2019 | 94.1% | $35.62 Million | $37.84 Million | $65.81 Million | $30.20 Million | ▼ -2.7 pp |
| 2018 | 96.8% | $57.24 Million | $59.14 Million | $77.13 Million | $19.89 Million | ▼ -13.0 pp |
| 2017 | 109.8% | $65.58 Million | $59.74 Million | $77.67 Million | $12.09 Million | ▲ +0.4 pp |
| 2016 | 109.4% | $96.49 Million | $88.18 Million | $105.40 Million | $8.91 Million | ▲ +11.0 pp |
| 2015 | 98.4% | $102.24 Million | $103.91 Million | $108.22 Million | $5.97 Million | ▲ +4.6 pp |
| 2014 | 93.8% | $19.80 Million | $21.10 Million | $23.01 Million | $3.21 Million | ▲ +99.7 pp |
| 2013 | -5.9% | $82.00K | $-1.40 Million | $198.00K | $116.00K | — |